Atlantic Health Cancer Consortium: local cancer care and clinical trial access
Official title: The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC Corp)
Funded at Atlantic Health System, INC. · NIH-11338269 · Data updated 2026-11-12
This program brings cancer prevention, screening, and treatment clinical trials and tissue-sample collection to people served by Atlantic Health in New Jersey to improve access to precision medicine.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Atlantic Health System, INC. NIH-funded |
| Lab location | 1 site (Morristown, United States) |
| Project start | August 27, 2019 |
| Project end | July 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $645,763 |
| NIH project number | 3UG1CA239772-06S1 |
| Project ID | NIH-11338269 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults and pediatric patients with cancer or at elevated risk who live in or receive care within the AHCC service area and are willing to consider trial participation or biospecimen donation.
✕Less likely to help
People who live outside the AHCC coverage area, are unwilling to join trials or donate samples, or whose cancer type is not included in available trials may not benefit directly.
What this research studies
The Atlantic Health Cancer Consortium connects local hospitals and clinics into a network that offers clinical trials for cancer prevention, screening, care delivery, and treatment while collecting blood and tissue samples for precision-medicine studies. If you have cancer or are at higher risk, you may be invited to enroll in trials, receive advanced imaging, or donate biospecimens at nearby community sites. The program serves about 73% of New Jersey’s population and expands trial access across urban and rural areas that have higher-than-average cancer rates. It also links community sites to national trial resources so patients can access treatments and studies that might otherwise be available only at large academic centers.
Why it matters
Potential benefit: Could give patients in the AHCC region earlier access to clinical trials, advanced imaging, and precision-medicine testing that may improve care options and outcomes.
How similar studies have gone: Other NCORP community sites have successfully expanded trial participation and biospecimen collection and improved local access to new treatments, although impact varies by the trials offered.
Where this research is happening
-
Atlantic Health System, INC.
Morristown, United States Active
Researchers
- Principal investigator: Whitman, Eric — Atlantic Health System, INC.
- Study coordinator: Whitman, Eric
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.